AbbVie Header AbbVie Header

X

CAS 2346620-54-8 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 2346620-54-8
Also known as: 2346620-54-8, Cs-0143220, [(3ar,4r,6r,6ar)-2,2-dimethyl-6-[2-oxo-4-(1h-1,2,4-triazol-1-yl)-1,2-dihydropyrimidin-1-yl]-tetrahydro-2h-furo[3,4-d][1,3]dioxol-4-yl]methyl 2-methylpropanoate
Molecular Formula
C18H23N5O6
Molecular Weight
405.4  g/mol
InChI Key
KHRVXGYHTALJEX-NMFUWQPSSA-N

1 2D Structure

CAS 2346620-54-8

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(3aR,4R,6R,6aR)-2,2-dimethyl-4-[2-oxo-4-(1,2,4-triazol-1-yl)pyrimidin-1-yl]-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl 2-methylpropanoate
2.1.2 InChI
InChI=1S/C18H23N5O6/c1-10(2)16(24)26-7-11-13-14(29-18(3,4)28-13)15(27-11)22-6-5-12(21-17(22)25)23-9-19-8-20-23/h5-6,8-11,13-15H,7H2,1-4H3/t11-,13-,14-,15-/m1/s1
2.1.3 InChI Key
KHRVXGYHTALJEX-NMFUWQPSSA-N
2.1.4 Canonical SMILES
CC(C)C(=O)OCC1C2C(C(O1)N3C=CC(=NC3=O)N4C=NC=N4)OC(O2)(C)C
2.1.5 Isomeric SMILES
CC(C)C(=O)OC[C@@H]1[C@@H]2[C@H]([C@@H](O1)N3C=CC(=NC3=O)N4C=NC=N4)OC(O2)(C)C
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 2346620-54-8

2. Cs-0143220

3. [(3ar,4r,6r,6ar)-2,2-dimethyl-6-[2-oxo-4-(1h-1,2,4-triazol-1-yl)-1,2-dihydropyrimidin-1-yl]-tetrahydro-2h-furo[3,4-d][1,3]dioxol-4-yl]methyl 2-methylpropanoate

2.3 Create Date
2019-12-06
3 Chemical and Physical Properties
Molecular Weight 405.4 g/mol
Molecular Formula C18H23N5O6
XLogP30.7
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count8
Rotatable Bond Count6
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area117
Heavy Atom Count29
Formal Charge0
Complexity738
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
URL Supplier Web Content
3258-02-4
Molnupiravir
Kimia Biosciences, established in 1993, is focused on manufacturing bulk drugs for various therapeutic se...
Kimia Biosciences, established in 1993, is focused on manufacturing bulk drugs for various therapeutic segments. With a strong emphasis on excellence and advanced technologies, Kimia aims to become a globally recognized company in both APIs and FDFs while upholding clean business practices. Kimia's state-of-the-art facilities at Village Bhondsi, Gurugram enable it to produce a wide range of APIs. Kimia also plans to establish its own facilities for lifestyle segments, adhering to international regulatory standards. Kimia aims to provide the best pharmaceutical products and support to consumers and healthcare professionals.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY